Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Isambert

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma GroupM Toulmonde, S Bonvalot, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma GroupM Toulmonde, S Bonvalot, P Méeus, et al.
ESMO Open|May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 studyC Baldini, E Charton, E Schultz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.
ESMO Open|August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 studyE Charton, C Baldini, Y Fayet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma GroupM Toulmonde, S Bonvalot, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma GroupM Toulmonde, S Bonvalot, P Méeus, et al.
ESMO Open|May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 studyC Baldini, E Charton, E Schultz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.
ESMO Open|August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 studyE Charton, C Baldini, Y Fayet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 6